Cargando…
The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer
Chronic inflammatory reactions have been proven to represent relevant mechanisms for the development and progression of cancer in numerous tumor entities. There is evidence that the platelet-to-lymphocyte ratio (PLR) is associated with the prognostic outcome. In rectal cancer, the prognostic role of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955057/ https://www.ncbi.nlm.nih.gov/pubmed/36832166 http://dx.doi.org/10.3390/diagnostics13040679 |
_version_ | 1784894263338729472 |
---|---|
author | Partl, Richard Paal, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Brunner, Thomas Baptist Langsenlehner, Tanja |
author_facet | Partl, Richard Paal, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Brunner, Thomas Baptist Langsenlehner, Tanja |
author_sort | Partl, Richard |
collection | PubMed |
description | Chronic inflammatory reactions have been proven to represent relevant mechanisms for the development and progression of cancer in numerous tumor entities. There is evidence that the platelet-to-lymphocyte ratio (PLR) is associated with the prognostic outcome. In rectal cancer, the prognostic role of this parameter has not yet been conclusively clarified. The aim of this study was to further clarify the prognostic significance of the pre-treatment PLR in patients with locally advanced rectal cancer (LARC). In the present study, 603 patients with LARC, who were treated with neoadjuvant chemoradiotherapy (nCRT) and subsequent surgical resection between 2004 and 2019, were retrospectively evaluated. The influence of clinico-pathological and laboratory factors on locoregional control (LC), metastasis-free survival (MFS) and overall survival (OS) was investigated. In univariate analyses, high PLR was significantly associated with worse LC (p = 0.017) and OS (p = 0.008). In multivariate analyses, the PLR remained an independent parameter for the LC (HR = 1.005, 95% CI: 1.000–1.009, p = 0.050). Pre-treatment lactate dehydrogenase (LDH) (HR: 1.005 95% CI:1.002–1.008; p = 0.001) and carcinoembryonic antigen (CEA) (HR: 1.006, 95% CI:1.003–1.009; p < 0.001) were independent predictors for MFS; additionally, age (HR: 1.052, 95% CI:1.023–1.081; p < 0.001), LDH (HR: 1.003, 95% CI:1.000–1.007; p = 0.029) and CEA (HR: 1.006, 95% CI:1.003–1.009; p < 0.001) independently predicted OS. Pre-treatment PLR before nCRT is an independent prognostic factor for LC in LARC, which could be used to further individualize tumor treatment. |
format | Online Article Text |
id | pubmed-9955057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99550572023-02-25 The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer Partl, Richard Paal, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Brunner, Thomas Baptist Langsenlehner, Tanja Diagnostics (Basel) Article Chronic inflammatory reactions have been proven to represent relevant mechanisms for the development and progression of cancer in numerous tumor entities. There is evidence that the platelet-to-lymphocyte ratio (PLR) is associated with the prognostic outcome. In rectal cancer, the prognostic role of this parameter has not yet been conclusively clarified. The aim of this study was to further clarify the prognostic significance of the pre-treatment PLR in patients with locally advanced rectal cancer (LARC). In the present study, 603 patients with LARC, who were treated with neoadjuvant chemoradiotherapy (nCRT) and subsequent surgical resection between 2004 and 2019, were retrospectively evaluated. The influence of clinico-pathological and laboratory factors on locoregional control (LC), metastasis-free survival (MFS) and overall survival (OS) was investigated. In univariate analyses, high PLR was significantly associated with worse LC (p = 0.017) and OS (p = 0.008). In multivariate analyses, the PLR remained an independent parameter for the LC (HR = 1.005, 95% CI: 1.000–1.009, p = 0.050). Pre-treatment lactate dehydrogenase (LDH) (HR: 1.005 95% CI:1.002–1.008; p = 0.001) and carcinoembryonic antigen (CEA) (HR: 1.006, 95% CI:1.003–1.009; p < 0.001) were independent predictors for MFS; additionally, age (HR: 1.052, 95% CI:1.023–1.081; p < 0.001), LDH (HR: 1.003, 95% CI:1.000–1.007; p = 0.029) and CEA (HR: 1.006, 95% CI:1.003–1.009; p < 0.001) independently predicted OS. Pre-treatment PLR before nCRT is an independent prognostic factor for LC in LARC, which could be used to further individualize tumor treatment. MDPI 2023-02-11 /pmc/articles/PMC9955057/ /pubmed/36832166 http://dx.doi.org/10.3390/diagnostics13040679 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Partl, Richard Paal, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Brunner, Thomas Baptist Langsenlehner, Tanja The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer |
title | The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer |
title_full | The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer |
title_fullStr | The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer |
title_full_unstemmed | The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer |
title_short | The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer |
title_sort | pre-treatment platelet-to-lymphocyte ratio as a prognostic factor for loco-regional control in locally advanced rectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955057/ https://www.ncbi.nlm.nih.gov/pubmed/36832166 http://dx.doi.org/10.3390/diagnostics13040679 |
work_keys_str_mv | AT partlrichard thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT paalkatarzyna thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT stranzbettina thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT hasslereva thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT magyarmarton thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT brunnerthomasbaptist thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT langsenlehnertanja thepretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT partlrichard pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT paalkatarzyna pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT stranzbettina pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT hasslereva pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT magyarmarton pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT brunnerthomasbaptist pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer AT langsenlehnertanja pretreatmentplatelettolymphocyteratioasaprognosticfactorforlocoregionalcontrolinlocallyadvancedrectalcancer |